Collplant Biotechnologies Ltd (CLGN)

Apr 23, 2025

Collplant stock hits 52-week low at $2.14 amid market challenges By Investing.com - Investing.com South Africa

Apr 23, 2025

Apr 23, 2025

Collplant stock hits 52-week low at $2.14 amid market challenges - Investing.com India

Apr 23, 2025

Apr 15, 2025

CollPlant's Collink.3D® BioInks and Technologies Offer a Relevan - GuruFocus

Apr 15, 2025

Apr 15, 2025

FDA Animal Testing Phase-Out: How CollPlant's BioInk Tech Could Revolutionize Drug Safety Studies - Stock Titan

Apr 15, 2025

Apr 03, 2025

Collplant stock hits 52-week low at $2.47 amid market challenges By Investing.com - Investing.com South Africa

Apr 03, 2025

Apr 03, 2025

Collplant stock hits 52-week low at $2.47 amid market challenges - Investing.com India

Apr 03, 2025

Mar 29, 2025

D. Boral Capital Reaffirms “Buy” Rating for CollPlant Biotechnologies (NASDAQ:CLGN) - Defense World

Mar 29, 2025

Mar 28, 2025

Collplant plans clinical trials for dermal filler and advances regenerative implants - MSN

Mar 28, 2025

Mar 28, 2025

Here's Why We're A Bit Worried About CollPlant Biotechnologies' (NASDAQ:CLGN) Cash Burn Situation - simplywall.st

Mar 28, 2025

Mar 28, 2025

When Will CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Breakeven? - Yahoo

Mar 28, 2025

Mar 27, 2025

CollPlant Biotechnologies (CLGN) to Release Earnings on Thursday - Defense World

Mar 27, 2025

Mar 27, 2025

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 27, 2025

Mar 27, 2025

CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings Call Highlights: Navigating Revenue ... - Yahoo

Mar 27, 2025

Mar 27, 2025

CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings Call Highl - GuruFocus

Mar 27, 2025

Mar 27, 2025

CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings Call Highlights: Navigating Revenue ... By GuruFocus - Investing.com Canada

Mar 27, 2025

Mar 27, 2025

CollPlant Biotechnologies Ltd. (NASDAQ:CLGN) Sees Large Decline in Short Interest - Defense World

Mar 27, 2025

Mar 27, 2025

COLLPLANT BIOTECHNOLOGIES REPORTS 2024 FINANCIAL RESULTS AND PROVIDES A CORPORATE UPDATE - StreetInsider.com

Mar 27, 2025

Mar 27, 2025

Earnings call transcript: Collplant Biotechnologies Q4 2024 misses forecasts - Investing.com India

Mar 27, 2025

Mar 27, 2025

CollPlant Biotechnologies Reports 2024 Financial Results - TipRanks

Mar 27, 2025

Mar 26, 2025

CollPlant’s Earnings Call: Mixed Outlook Amid Innovations - TipRanks

Mar 26, 2025

Mar 26, 2025

SEC Form 20-F filed by CollPlant Biotechnologies Ltd - Quantisnow

Mar 26, 2025

Mar 26, 2025

Collplant Biotechnologies Ltd reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 26, 2025

Mar 25, 2025

Collplant stock hits 52-week low at $2.9 amid market challenges - Investing.com Australia

Mar 25, 2025

Mar 25, 2025

Collplant stock hits 52-week low at $2.9 amid market challenges By Investing.com - Investing.com South Africa

Mar 25, 2025

Mar 25, 2025

What To Expect From CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings - GuruFocus

Mar 25, 2025

Mar 24, 2025

Collplant Biotechnologies Ltd expected to post a loss of 28 cents a shareEarnings Preview - TradingView

Mar 24, 2025

Mar 24, 2025

CollPlant Biotechnologies (CLGN) to Release Quarterly Earnings on Wednesday - Defense World

Mar 24, 2025

Mar 19, 2025

COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2024 FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION - Quantisnow

Mar 19, 2025

Mar 18, 2025

Analyzing Anteris Technologies Global (NASDAQ:AVR) & CollPlant Biotechnologies (NASDAQ:CLGN) - Defense World

Mar 18, 2025

Mar 05, 2025

Collplant stock hits 52-week low at $3.07 amid market challenges By Investing.com - Investing.com South Africa

Mar 05, 2025

Mar 05, 2025

Collplant stock hits 52-week low at $3.07 amid market challenges - Investing.com India

Mar 05, 2025

Feb 25, 2025

Collplant stock hits 52-week low at $3.24 amid market challenges - Investing.com India

Feb 25, 2025

Feb 25, 2025

Collplant stock hits 52-week low at $3.24 amid market challenges By Investing.com - Investing.com South Africa

Feb 25, 2025

Feb 25, 2025

Israel-based CollPlant expands distribution for VergenixSTR in Europe and Asia - BSA bureau

Feb 25, 2025

Feb 24, 2025

CollPlant expands VergenixSTR distribution in Europe and Asia By Investing.com - Investing.com Australia

Feb 24, 2025

Feb 24, 2025

CollPlant expands European and Asian distribution of soft tissue repair matrix - Yahoo Finance

Feb 24, 2025

Feb 24, 2025

CollPlant Expands Vergenix STR Distribution Across Europe And Asia - Nasdaq

Feb 24, 2025

Feb 24, 2025

Medical Breakthrough: CollPlant's Tendon Treatment Enters 4 New MarketsWhy It Matters - StockTitan

Feb 24, 2025

Feb 24, 2025

CollPlant Expands Distribution for its VergenixSTR Product in Europe and Asia - PR Newswire

Feb 24, 2025

Feb 12, 2025

CollPlant secures U.S. patent for dermal filler - Investing.com India

Feb 12, 2025

Feb 12, 2025

CollPlant secures U.S. patent for dermal filler By Investing.com - Investing.com Australia

Feb 12, 2025

Feb 12, 2025

CollPlant Biotechnologies Provides a Corporate Update - PR Newswire

Feb 12, 2025

Feb 10, 2025

Tissue Engineering Market: Key Player Profiles, Industry US$ - openPR

Feb 10, 2025

Feb 06, 2025

CollPlant Biotechnologies (NASDAQ:CLGN) Earns Buy Rating from D. Boral Capital - Defense World

Feb 06, 2025

Jan 20, 2025

Contrasting CollPlant Biotechnologies (NASDAQ:CLGN) and Pathfinder Cell Therapy (OTCMKTS:PFND) - Defense World

Jan 20, 2025